Glucose Aguettant (Glucose Monohydrate)

Glucose Aguettant is used in clinical settings where rapid carbohydrate provision and fluid balance are required.

• Intravenous fluid and electrolyte replacement in patients unable to tolerate oral intake.
• Component of parenteral nutrition formulas for short‑term or peri‑operative support.
• Energy source during hypoglycaemia or metabolic stress.
• Adjunct in resuscitation protocols to maintain intravascular volume.
• Support for patients receiving dialysis or continuous renal replacement therapy.

Adverse reactions to Glucose Aguettant are generally related to its osmotic properties and the underlying clinical condition.

Common

• Mild hyperglycaemia.
• Local irritation at the infusion site.
• Transient electrolyte shifts (e.g., sodium, potassium).
• Nausea or vomiting when administered rapidly.

Serious

• Severe hyperglycaemia requiring insulin therapy.
• Fluid overload leading to pulmonary oedema.
• Hyperosmolar hyperglycaemic state.
• Allergic reaction such as urticaria or anaphylaxis.

When prescribing Glucose Aguettant, clinicians should evaluate patient‑specific factors and monitor relevant parameters.

• Assess blood glucose levels before and during infusion.
• Monitor fluid balance and signs of overload, especially in cardiac or renal impairment.
• Adjust dose in patients with diabetes mellitus or insulin resistance.
• Use caution in neonates, infants, and the elderly due to altered metabolism.
• Verify compatibility with other intravenous medications before co‑administration.
• Ensure sterile technique to prevent infection.

Glucose Aguettant may interact with other agents administered intravenously or affect systemic metabolic pathways.

Avoid

• Co‑administration with high‑dose insulin without glucose monitoring, which can precipitate severe hypoglycaemia.
• Simultaneous infusion of hypertonic solutions that could exacerbate osmotic shifts.
• Use with medications that contain potassium or sodium in excess, risking electrolyte imbalance.

Use with caution

• Concurrent use of diuretics that alter fluid status.
• Administration alongside vasopressors, as volume changes may affect hemodynamics.
• Combination with other carbohydrate‑containing solutions, which may increase total caloric load.
• Overlap with contrast agents, requiring monitoring of renal function.